“If you wait long enough, in the parlance of Wall Street, you get your face ripped off."

Dec 5, 2023

Andrew Lo proposed a $30bn cancer “megafund” a decade ago to combine drug testing projects to diversify risk.

Aug 29, 2023

The decision to license or sell a drug depends on profitability, strategic mission, and whether a company “believes” in the science of a drug.

May 10, 2023

"If you combine multiple diseases into a single financial portfolio, all of a sudden the risk-reward trade off becomes more attractive."

Feb 16, 2023